Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyoshi Harashima

Showing results (321-330 of 485) with videos related to

Pageof 49
Sort By:
ACS Applied Materials & Interfaces|July 16, 2020
Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA DeliveryNiko Kimura, Masatoshi Maeki, Yusuke Sato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 11, 2015
Mitochondrial delivery of Coenzyme Q10 via systemic administration using a MITO-Porter prevents ischemia/reperfusion injury in the mouse liverYuma Yamada, Kohei Nakamura, Jiro Abe, et al.
International Journal of Pharmaceutics|May 25, 2015
Effect of hydrophobic scaffold on the cellular uptake and gene transfection activities of DNA-encapsulating liposomal nanoparticles via intracerebroventricular administrationHidetaka Akita, Taichi Nakatani, Kimiko Kuroki, et al.
Molecular Pharmaceutics|August 5, 2021
Maximizing the Oral Bioavailability of Poorly Water-Soluble Drugs Using Novel Oil-Like Materials in Lipid-Based FormulationsSaed Abbasi, Haruki Higashino, Yusuke Sato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 28, 2014
A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinomaHidetaka Akita, Ryohei Ishiba, Ryohei Togashi, et al.
European Journal of Pharmacology|February 9, 2002
Troglitazone suppresses cell growth of KU812 cells independently of PPARgammaAkihito Abe, Yoshimitsu Kiriyama, Masako Hirano, et al.
Accounts of Chemical Research|January 3, 2012
Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptidesIkuhiko Nakase, Hidetaka Akita, Kentaro Kogure, et al.
Acta Biomaterialia|November 17, 2019
Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticlesYusuke Sato, Nana Okabe, Yusuke Note, et al.
Journal of Pharmaceutical Sciences|December 30, 2014
Efficient and High-Speed Transduction of an Antibody into Living Cells Using a Multifunctional Nanocarrier System to Control Intracellular TraffickingYuma Yamada, Sandra Milena Vergara Perez, Mai Tabata, et al.
Mitochondrion|October 9, 2020
The use of a MITO-Porter to deliver exogenous therapeutic RNA to a mitochondrial disease's cell with a A1555G mutation in the mitochondrial 12S rRNA gene results in an increase in mitochondrial respiratory activityYuma Yamada, Minako Maruyama, Tomoko Kita, et al.
Pageof 49

Showing results (321-330 of 485) with videos related to

Sort By:
Pageof 49
ACS Applied Materials & Interfaces|July 16, 2020
Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA DeliveryNiko Kimura, Masatoshi Maeki, Yusuke Sato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 11, 2015
Mitochondrial delivery of Coenzyme Q10 via systemic administration using a MITO-Porter prevents ischemia/reperfusion injury in the mouse liverYuma Yamada, Kohei Nakamura, Jiro Abe, et al.
International Journal of Pharmaceutics|May 25, 2015
Effect of hydrophobic scaffold on the cellular uptake and gene transfection activities of DNA-encapsulating liposomal nanoparticles via intracerebroventricular administrationHidetaka Akita, Taichi Nakatani, Kimiko Kuroki, et al.
Molecular Pharmaceutics|August 5, 2021
Maximizing the Oral Bioavailability of Poorly Water-Soluble Drugs Using Novel Oil-Like Materials in Lipid-Based FormulationsSaed Abbasi, Haruki Higashino, Yusuke Sato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 28, 2014
A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinomaHidetaka Akita, Ryohei Ishiba, Ryohei Togashi, et al.
European Journal of Pharmacology|February 9, 2002
Troglitazone suppresses cell growth of KU812 cells independently of PPARgammaAkihito Abe, Yoshimitsu Kiriyama, Masako Hirano, et al.
Accounts of Chemical Research|January 3, 2012
Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptidesIkuhiko Nakase, Hidetaka Akita, Kentaro Kogure, et al.
Acta Biomaterialia|November 17, 2019
Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticlesYusuke Sato, Nana Okabe, Yusuke Note, et al.
Journal of Pharmaceutical Sciences|December 30, 2014
Efficient and High-Speed Transduction of an Antibody into Living Cells Using a Multifunctional Nanocarrier System to Control Intracellular TraffickingYuma Yamada, Sandra Milena Vergara Perez, Mai Tabata, et al.
Mitochondrion|October 9, 2020
The use of a MITO-Porter to deliver exogenous therapeutic RNA to a mitochondrial disease's cell with a A1555G mutation in the mitochondrial 12S rRNA gene results in an increase in mitochondrial respiratory activityYuma Yamada, Minako Maruyama, Tomoko Kita, et al.
Pageof 49